Cilostazol: a Review of Basic Mechanisms and Clinical Uses

Primarily used in the treatment of intermittent claudication, cilostazol is a 2-oxyquinolone derivative that works through the inhibition of phosphodiesterase III and related increases in cyclic adenosine monophosphate (cAMP) levels. However, cilostazol has been implicated in a number of other basic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cardiovascular drugs and therapy Jg. 36; H. 4; S. 777 - 792
Hauptverfasser:	Kherallah, Riyad Y., Khawaja, Muzamil, Olson, Michael, Angiolillo, Dominick, Birnbaum, Yochai
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	New York Springer US 01.08.2022 Springer Nature B.V
Schlagworte:	Adenosine diphosphate Adenosine monophosphate Aspirin Blood platelets Cardiology Cardiovascular disease Cardiovascular diseases Cardiovascular system Cyclic AMP Diabetes Enzymes Intermittent claudication Intervention Ischemia Kinases Medicine Medicine & Public Health Multidrug resistance Phosphodiesterase Phosphorylation Population studies Proteins Reperfusion Restenosis Review Article Smooth muscle Phosphodiesterase inhibitor Platelet inhibition Cilostazol
ISSN:	0920-3206, 1573-7241, 1573-7241
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!